NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

The DCVAX trial is the longest running trial in the history of biotech trials ever, stemming back to the last century from bottom to top. There is no biotech from start to finish, that has run that long. What that implies is that NWBO is highly inefficient in bringing a developing drug to market. The reason why that is is that there are lawyers running the business, not experts actually knowing how to develop a drug and bringing it to market avoiding all the pitfalls and problems LP and consorts have fallen for. Let alone investing in the wrong projects such as real estate and production capacity.

That doesnt mean it will never be launched, it will, even with one hell of an OS tail Im sure and also some of the wonderful advantages you described. However the moment it will get worldwide steam (2-3 years after market) it most probably is already old technology.
Again, the whole medical IMMU drug industry is moving towards developing drugs without the combination of old SOC. Many IMMU therapies will be launched in the next 3-10 years
You can deny it but I would suggest to just Google and you find plenty of ample examples of promising IMMU therapies (there are 650 currently in trial). DCVAX is cutting edge as long as it is not overtaken by IMMU therapies treating without the combi of SOC and I, therefore, give L 3 years from now before its obsolete.